Research Topic · Peer-Reviewed

Colon Adenocarcinoma

Colon adenocarcinoma is a type of cancer that affects the colon, which is a part of the large intestine. It is the most common type of cancer that affects the colon, and it can be very dangerous if not detected early. Hematology and Oncology Research have contributed a lot to the understanding of colon adenocarcinom…

Curated from this journal's research 📚 3 peer-reviewed articles cited Cited 2× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

Colon adenocarcinoma is a type of cancer that affects the colon, which is a part of the large intestine. It is the most common type of cancer that affects the colon, and it can be very dangerous if not detected early. Hematology and Oncology Research have contributed a lot to the understanding of colon adenocarcinoma and the development of effective treatment methods. Some of the common risk factors for colon adenocarcinoma include age (people over 50 are at a higher risk), a history of colorectal polyps, a family history of colon cancer, inflammatory bowel disease, and a diet that is high in red meat and fat. Symptoms of colon adenocarcinoma can include diarrhea or constipation, blood in stool, abdominal pain and cramping, and unintentional weight loss. In terms of treatment, there are several options available that will depend on the stage of the cancer and other factors. Surgery is often the first line of treatment for this type of cancer, and radiation therapy and chemotherapy may also be recommended depending on the individual case. The field of hematology and oncology is constantly evolving, with new diagnostic tools, treatments, and research being conducted every day. Through ongoing research and clinical trials, scientists hope to understand this type of cancer better and develop more targeted treatments that can improve outcomes for patients. By staying up-to-date on the latest findings and advancements in the field, physicians and patients can work together to improve the management of colon adenocarcinoma and other cancers.

Research published in this journal

3 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 3 articles above have been cited 2 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Colon Adenocarcinoma, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.